FDA published a draft guidance document on Jan. 2, 2025 that provides considerations for complying with 21 Code of Federal Regulations (CFR) 211.110 (1). This specific section of the CFR focuses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback